Search Results - "Wald, J.W."

Renal Failure Is Not a Contraindication to Left Ventricular Assist Device Implantation by Kilic, A, Chen, C.W, Gaffey, A.C, Wald, J.W, Acker, M.A, Atluri, P

Get full text

Outcomes of Veno-Arterial Extracorporeal Membrane Oxygenation in Cardiogenic Shock in the Elderly. Large Single Center Experience by Gentile, J.I, Atluri, P, Desai, N.D, Vallabhajosyula, P, Wald, J.W, Rame, J.E, Gutsche, J.T, Horak, J, Acker, M.I, Bermudez, C.A

Get full text

ECMO Use in INTERMACS 1 Patients as a Bridge to LVAD with Intention to Transplant versus Bridge to Direct Heart Transplant. Single Center Experience by Gentile, J.I, Molina, M.R, Atluri, P, Rame, J.E, Wald, J.W, Birati, E.Y, Goldberg, L.R, McLean, R, Acker, M.I, Bermudez, C.A

Get full text

Mitral Regurgitation Is Associated with Right Ventricular Pulsatile Loading and Early Right Heart Failure After Left Ventricular Assist Device by Grandin, E.W, Gulati, A.A, Troutman, G.S, Zamani, P, Mazurek, J.A, Birati, E.Y, Wald, J.W, Margulies, K.B, Atluri, P, Rame, J.E

Get full text

Clinical Outcomes Reveal a Spectrum of Early Right Heart Failure after Left Ventricular Assist Device by Grandin, E.W, Troutman, G.S, Gulati, A.A, Zamani, P, Mazurek, J.A, Birati, E.Y, Wald, J.W, Margulies, K.B, Atluri, P, Rame, J.E

Get full text

Changes in Lipid Profile Following Durable Mechanical Circulatory Support: Confirming the “Lipid Paradox” in Heart Failure by Telukuntla, K.S, Hanff, T.C, Grandin, E.W, Mazurek, J.A, Howard, J.L, Wald, J.W, Goldberg, L.R, Jessup, M.L, Acker, M.A, Margulies, K.B, Atluri, P, Rame, J.E, Birati, E.Y

Get full text

Dynamic BMI Changes in Patients Implanted with Continuous Flow Left Ventricular Assist Devices: Evidence for Reversibility of Cardiac Cachexia and Impact on Survival by Kobrin, D.M, Donnelly, J.P, Acker, A.L, Howard, J.L, Zalewski, C.M, Walsh, S.L, Hill, C.E, O’Hara, M.L, Marble, J.F, Atluri, P, Wald, J.W, Goldberg, L.R, Woo, Y.J, Acker, M.A, Rame, J.E

“…Purpose Pre-implant body mass index (BMI) is not associated with overall survival in patients receiving continuous flow left ventricular assist devices (CF…”
Get full text

75 Does the “Obesity Paradox” in Chronic Heart Failure Fade after Mechanical Circulatory Support with Continuous Flow Devices: Analysis from the Interagency Registry for Mechanically Assisted Circulatory Support by Donnelly, J.P, Woo, Y.J, Morris, R.J, Goldberg, L.R, Wald, J.W, Atluri, P, O'Hara, M.L, Breuer, K.A, Marble, J.F, Avrahami, N.Y, Arabia, F.A, Rogers, J.G, Acker, M.A, Rame, J.E

“…Purpose In the “obesity paradox,” overweight patients with chronic heart failure demonstrate increased survival as compared to their lean counterparts. Since…”
Get full text

430: Clinical outcomes after cardiac transplantation in muscular dystrophy patients by Wu, R.S, Brown, R.N, Yancy, C.W, Wald, J.W, Kaiser, P, Kirklin, N.M, Garry, D.J, Mammen, P.P.A

Get full text

(472) - Regional Systems of Care in Cardiogenic Shock Can Improve Outcomes: Penn Medicine Shock Team and Community Relationships by Wald, J.W., Parikh, A., Clay, W., Brown, A., Spelde, A., Hoenisch, K., Olia, S., Giri, J., Frankel, D., Gordon, E., Cevasco, M., Bermudez, C.

Get full text

Changes in Waitlist Survival for Patients Bridged by VA-ECMO in the United States by Hanff, T.C., Harhay, M.O., Atluri, P., Acker, M.A., Wald, J.W., Goldberg, L.R., Birati, E.Y.

“…Patients supported by VA-ECMO are prioritized for heart transplantation under the new United States donor allocation system, which is intended to decrease…”
Get full text

Effect of Anesthesia on Cardiac Hemodynamics in patients undergoing durable LVAD Implantation: The EACHLVAD Study by Hanff, T.C., Patel, P.A., Kurcik, K.L., Rao, S., Kimmel, S.E., Putt, M.E., Atluri, P., Bermudez, C.A., Acker, M.A., Birati, E.Y., Rame, J.E., Wald, J.W.

“…Right ventricular (RV) dysfunction is often unmasked or exacerbated during implantation of a left ventricular assist device (LVAD). Prior to LVAD implantation,…”
Get full text

Effect of Anesthesia on Cardiac Hemodynamics in patients undergoing durable LVAD Implantation: The EACH LVAD Study by Hanff, T.C., Patel, P.A., Kurcik, K.L., Rao, S., Kimmel, S.E., Putt, M.E., Atluri, P., Bermudez, C.A., Acker, M.A., Birati, E.Y., Rame, J.E., Wald, J.W.

Get full text

(953) - Durability of Medical Therapy for Heartware LVAD Thrombosis by Wald, J.W., Justice, C., Guarracino, D., Marble, J., Laverty-Wilson, E., Birati, E., Bermudez, C., Atluri, P., Acker, M., Rame, E.

Get full text

Impact of Multiorgan Procurement on Survival Following Heart Transplantation by Magruder, J., Sperry, A., Vasquez, C.R., Smood, B.F., Grimm, J.C., Atluri, P., Bermudez, C., Acker, M.A., Wald, J.W., Suzuki, Y., Cevasco, M.

“…Patient and donor risk factors for post-heart transplant mortality have been identified, but the relevance of the procurement procedure itself has not been…”
Get full text

Iron Sucrose in Patients with Left Ventricular Assist Devices and Iron Deficiency by Peters, C.J., Domenico, C.M., Hanff, T.C., Atluri, P., Zhang, R., Genuardi, M.V., Mazurek, J.A., Urgo, K.A., Wald, J.W., Tanna, M.S., Birati, E.Y.

“…Intravenous iron repletion in patients with heart failure with reduced ejection fraction (HFrEF) and iron deficiency has been shown to safely improve…”
Get full text

The Role of Human Leukocyte Antigen Sensitization as a Risk Factor for Mortality in Patients Bridged to Heart Transplantation with VA-ECMO by Hanff, T.C., Harhay, M.O., Kimmel, S.E., Molina, M., Acker, M.A., Bermudez, C., Atluri, P., Mazurek, J.A., Wald, J.W., McLean, R.C., Goldberg, L.R., Birati, E.Y.

“…Patients bridged to heart transplantation (BTT) with VA-ECMO have increased mortality in the first post-transplant year. This has been observed even after…”
Get full text

VA-ECMO as a Bridge to Heart Transplantation: Quantification of Mortality Trends over the Last Decade by Hanff, T.C., Harhay, M.O., Kimmel, S.E., Molina, M., Acker, M.A., Bermudez, C., Atluri, P., Mazurek, J.A., Wald, J.W., McLean, R.C., Goldberg, L.R., Birati, E.Y.

“…VA-ECMO technology has rapidly progressed over the last twenty years, leading to expanded indications and usage. Historically, patients bridged to transplant…”
Get full text

Management of the sensitized cardiac recipient: the use of plasmapheresis and intravenous immunoglobulin by Leech, S.H., Lopez-Cepero, M., LeFor, W.M., DiChiara, L., Weston, M., Furukawa, S., Macha, M., Singhal, A., Wald, J.W., Nikolaidis, L.A., McClurken, J.B., Bove, A.A.

“…:  Previously, we reported that the combination of plasmapheresis (PP) and intravenous immunoglobulin (IVIg) allow sensitized patients to undergo orthotopic…”
Get full text